5411-28-4 Purity
96%
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1982, vol. 18, # 2, p. 134 - 138[2] Khimiya Geterotsiklicheskikh Soedinenii, 1982, vol. 18, # 2, p. 176 - 180
Reference: [1] Patent: WO2008/124518, 2008, A1, . Location in patent: Page/Page column 18
Reference: [1] European Journal of Medicinal Chemistry, 2016, vol. 117, p. 47 - 58
[2] Journal of Agricultural and Food Chemistry, 2017, vol. 65, # 26, p. 5397 - 5403
[3] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 6, p. 2019 - 2024
[4] Patent: CN105503832, 2016, A, . Location in patent: Paragraph 0065; 0066; 0069; 0070
[5] Patent: WO2008/98104, 2008, A1, . Location in patent: Page/Page column 217
Reference: [1]Chemistry of Heterocyclic Compounds,1982,vol. 18,p. 134 - 138
Khimiya Geterotsiklicheskikh Soedinenii,1982,vol. 18,p. 176 - 180
Reference: [1]Patent: WO2008/124518,2008,A1 .Location in patent: Page/Page column 18
Reference: [1]Bach; Krüger
[Synlett, 1998, # 11, p. 1185 - 1186]
[2]Bach, Thorsten; Krüger, Lars
[European Journal of Organic Chemistry, 1999, # 9, p. 2045 - 2057]
[3]Current Patent Assignee: SYNTA PHARMACEUTICALS CORP. - WO2009/17818, 2009, A1
Location in patent: Page/Page column 49-50
[4]Current Patent Assignee: SYNTA PHARMACEUTICALS CORP. - WO2007/87429, 2007, A2
Location in patent: Page/Page column 115
* For details of the synthesis route, please refer to the original source to ensure accuracy.